Anticorps Monoclonal anti-Phospho-MEK1 (Ser298)

Phospho-MEK1 (Ser298) Monoclonal Antibody for Single Cell (Intra)

Hôte / Isotype

Mouse / IgG1

Réactivité testée

Humain

Applications

Single Cell (Intra)

Conjugaison

5CFLX Fluorescent Dye

CloneNo.

3F10G10

N° de cat : G68047-1-5C

Synonymes

ERK activator kinase 1, MAP kinase kinase 1, MAP2K1, MAPK/ERK kinase 1, MAPKK 1, MAPKK1, MEK 1, MEK1, MKK1, Phospho-MEK1 (Ser298), PRKMK1



Applications testées

Résultats positifs en Single Cell (Intra)10x Genomics Gene Expression Flex with Feature Barcodes and Multiplexing product.

Dilution recommandée

ApplicationDilution
SINGLE CELL (INTRA)SINGLE CELL (INTRA) : <0.5ug/test
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

G68047-1-5C cible Phospho-MEK1 (Ser298) dans les applications de Single Cell (Intra) et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Mouse / IgG1
Clonalité Monoclonal
Type Anticorps
Immunogène Peptide
Nom complet mitogen-activated protein kinase kinase 1
Masse moléculaire calculée 43 kDa
Numéro d’acquisition GenBankBC139729
Symbole du gène MEK1
Identification du gène (NCBI) 5604
Conjugaison 5CFLX Fluorescent Dye
Forme Liquide
Méthode de purification
Tampon de stockage PBS with 1mM EDTA and 0.09% sodium azide
Conditions de stockage2-8°C Stable for one year after shipment. 20ul contiennent 0,1% de BSA.

Informations générales

MAP2K1 encodes MAPK1, also known as MEK1. MEK1 variants can enhance MEK1 expression and ERK1 phosphorylation that together lead to continuous activation of MEK/ERK signaling pathway. MEK1 bind directly to ERK2 through a region in the N terminus of MEK. In addition, a proline-rich (PR) regulatory sequence in MEK is also involved in MEK-ERK association and signal propagation. The coupling between MEK1 and ERK2 is enhanced through phosphorylation on S298 in the MEK1 PR region, whereas phosphorylation on MEK1 T292 releases the complex. MEK1 T292 is a substrate of ERK2, but the site is also phosphorylated at a basal level when ERK2 is inhibited, suggesting several regulators of this site . Although the S298 site in MEK2 has been conserved, it lacks the T292 phosphorylation site, and it is not a substrate of PAK1. (PMID: 31972311, PMID: 17928366, PMID: 22177953)

{{ptg:RelatedPrimaryAntibodies}}